6
Participants
Start Date
January 31, 2014
Primary Completion Date
May 31, 2015
Study Completion Date
September 30, 2015
Omegaven 10%
intravenous administration 10% (w/v) fish oil emulsion (Omegaven) for 1 hour on three consecutive days at a dose of 0.2 g/kg bodyweight/hr.
Intralipid 20%
intravenous administration of 20% (w/v) lipid-control (Intralipid®), for 1 hour on three consecutive days at a dose of 0.2 g/kg bodyweight/hr.
Radboud University Medical Center, Nijmegen
Radboud University Medical Center
OTHER